Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 15, 2020 - Issue
Submit an article Journal homepage
204
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Symptoms, Management and Healthcare Utilization of COPD Patients During the COVID-19 Epidemic in Beijing

Ying LiangDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, People's Republic of China
,
Chun ChangDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, People's Republic of China
,
Yahong ChenDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, People's Republic of China
,
Fawu DongDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, People's Republic of China
,
Linlin ZhangDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, People's Republic of China
&
Yongchang SunDepartment of Respiratory and Critical Care Medicine, Peking University Third Hospital, Beijing, 100191, People's Republic of ChinaCorrespondence[email protected]
Pages 2487-2494 | Published online: 14 Oct 2020

References

  • Global Strategy for the Diagnosis. Management and prevention of chronic obstructive pulmonary disease, Global initiative for chronic obstructive lung disease (GOLD). 2020 Available from: http://www.goldcopd.org/. Accessed 120, 2020.
  • AdeloyeD, ChuaS, LeeC, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415. doi:10.7189/jogh.05.02041526755942
  • WangC, XuJ, YangL, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China pulmonary health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-929650248
  • ZhaoQ, MengM, KumarR, et al. The impact of COPD and smoking history on the severity of Covid-19: a systemic review and meta-analysis. J Med Virol. 2020. doi:10.1002/jmv.25967
  • WangL, HeW, YuX, et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80(6):639–645. doi:10.1016/j.jinf.2020.03.01932240670
  • Chronic obstructive pulmonary disease group of Chinese Thoracic Society, Chronic obstructive pulmonary disease of Chinese Association of Chest Physician. [Medical management and prevention instruction of chronic obstructive pulmonary disease during the coronavirus disease 2019 epidemic]. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E034.
  • GOLD. COVID-19 Guidance. Available from: http://www.goldcopd.org/. Accessed 517, 2020.
  • BestallJC, PaulEA, GarrodR, et al. Usefulness of the medical research council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.58110377201
  • JonesPW, HardingG, BerryP, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.0010250919720809
  • IngebrigtsenTS, MarottJL, NordestgaardBG, et al. Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population. J Gen Intern Med. 2015;30(1):51–59. doi:10.1007/s11606-014-3029-025245885
  • SockriderM, Tal-SingerR. Managing your chronic lung disease during the COVID-19 pandemic. Am J Respir Crit Care Med. 2020;202(2):5–6. doi:10.1164/rccm.2020C8
  • Centers for Disease Control and Prevention (U.S.). Coronavirus disease 2019 (COVID-19)/people who need extra precautions/people who are at higher risk/people with moderate to severe asthma. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extraprecautions/index.html. Accessed 59, 2020.
  • ShakerMS, OppenheimerJ, GraysonM, et al. COVID-19: pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract. 2020;8(5):1477–1488.e5. doi:10.1016/j.jaip.2020.03.01232224232
  • LiuF, JiangY, XuG, DingZ. Effectiveness of telemedicine intervention for chronic obstructive pulmonary disease in China: a systematic review and meta-analysis. Telemed J E Health. 2020;26(9):1075–1092. doi:10.1089/tmj.2019.021532069170
  • SorianoJB, KendrickPJ, PaulsonKR; GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Respir Med. 2020;8(6):585–596. doi:10.1016/S2213-2600(20)30105-332526187
  • FangL, GaoP, BaoH, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018;6(6):421–430. doi:10.1016/S2213-2600(18)30103-629650407
  • TøttenborgSS, ThomsenRW, JohnsenSP, et al. Determinants of smoking cessation in patients with COPD treated in the outpatient setting. Chest. 2016;150(3):554–562. doi:10.1016/j.chest.2016.05.02027262226
  • FanJ, CongS, WangN, et al. [Smoking cessation in chronic obstructive pulmonary disease patients aged 40 years or older in China, 2014–2015]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(7):1021–1027.32741164
  • SoJY, ZhaoH, VoelkerH, et al. Seasonal and regional variations in chronic obstructive pulmonary disease exacerbation rates in adults without cardiovascular risk factors. Ann Am Thorac Soc. 2018;15(11):1296–1303. doi:10.1513/AnnalsATS.201801-070OC30063372

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.